To enable this innovation, Medigene combined TCR-guided precision targeting with innate NK cell killing. The Company has developed a proprietary universal scaffold that allows its 3S TCRs to function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback